L.P. ACORN BIOVENTURES - 15 May 2025 SCHEDULE 13D/A Report for OnKure Therapeutics, Inc. Common stock, par value $0.0001 per share (OKUR)

Filing Manager: L.P. ACORN BIOVENTURES
Reporting Manager: Anders Hove
Security: OnKure Therapeutics, Inc. Common stock, par value $0.0001 per share
Symbol: OKUR
Shares outstanding: 12,849,204 shares
Disclosed Ownership: 2,839,674 shares
Ownership: 22%
Form type: SCHEDULE 13D/A
Filing time: 30 May 2025, 15:57:52 UTC
Date of event: 15 May 2025
SEC: View on sec.gov

Reporting Managers (5)

Name	Ownership	Shares Owned	sole voting power	Signature	Title	CIK
ACORN BIOVENTURES, L.P.	13%	1,709,944	1,709,944	Anders Hove	Manager of General Partner	0001766853
ACORN CAPITAL ADVISORS GP, LLC	13%	1,709,944	1,709,944	Anders Hove	Manager	0001813692
Anders Hove	22%	2,839,674	2,839,674	Anders Hove	Individually
ACORN BIOVENTURES 2, L.P.	8.8%	1,129,730	1,129,730	Anders Hove	Manager of General Partner	0001876405
Acorn Capital Advisors GP 2, LLC	8.8%	1,129,730	1,129,730	Anders Hove	Manager